| 0 |
Interleukin-5 Antagonist [EPC] |
1 |
0.0015 |
| 1 |
Guanylate Cyclase-C Agonist [EPC] |
2 |
0.0010 |
| 2 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
2 |
0.0003 |
| 3 |
Phosphodiesterase 3 Inhibitor [EPC] |
1 |
0.0002 |
| 4 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
1 |
0.0001 |
| 5 |
Cephalosporin Antibacterial [EPC] |
1 |
0.0001 |
| 6 |
beta3-Adrenergic Agonist [EPC] |
5 |
0.0001 |
| 7 |
Anti-anginal [EPC] |
1 |
0.0001 |
| 8 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
1 |
0.0001 |
| 9 |
Sympathomimetic-like Agent [EPC] |
2 |
0.0001 |
| 10 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
1 |
0.0001 |
| 11 |
Progesterone [EPC] |
1 |
0.0000 |
| 12 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1 |
0.0000 |
| 13 |
Interleukin-23 Antagonist [EPC] |
4 |
0.0000 |
| 14 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 15 |
Muscle Relaxant [EPC] |
1 |
0.0000 |
| 16 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 17 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 18 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 19 |
Cholinergic Nicotinic Agonist [EPC] |
1 |
0.0000 |
| 20 |
Thiazide Diuretic [EPC] |
3 |
0.0000 |
| 21 |
Azole Antifungal [EPC] |
2 |
0.0000 |
| 22 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 23 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 24 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 25 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
2 |
0.0000 |
| 26 |
Estrogen [EPC] |
2 |
0.0000 |
| 27 |
Partial Opioid Agonist [EPC] |
1 |
0.0000 |
| 28 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 29 |
Acetylcholine Release Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 31 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 32 |
Proton Pump Inhibitor [EPC] |
5 |
0.0000 |
| 33 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 35 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Factor Xa Inhibitor [EPC] |
2 |
0.0000 |
| 37 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 38 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 39 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 41 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
3 |
0.0000 |
| 42 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 43 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 44 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 45 |
GLP-1 Receptor Agonist [EPC] |
2 |
0.0000 |
| 46 |
Benzodiazepine [EPC] |
3 |
0.0000 |
| 47 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |
| 48 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 49 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 50 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 51 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 52 |
Vitamin C [EPC] |
1 |
0.0000 |
| 53 |
Corticosteroid [EPC] |
3 |
0.0000 |
| 54 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 55 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 56 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 57 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |